You need to enable JavaScript to run this app.
Regulatory Recon: Vertex Stops Cystic Fibrosis Combination Trial After No Benefit Found Aurinia Lupus Drug Meets Endpoint Despite 13 Patient Deaths (16 August 2016)
Recon
Regulatory News
Michael Mezher